指南与共识免疫规划卫生政策与健康促进

肯尼亚季节性流感疫苗推荐的制定:国家免疫技术咨询组(NITAG)的流程与挑战

Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
指南 / 共识 · Vaccine · 2018-11-27

本文描述了肯尼亚国家免疫技术咨询组(KENITAG)在2014至2016年间应卫生部要求,评估是否将季节性流感疫苗纳入国家免疫规划的流程与遇到的挑战。KENITAG建立了推荐框架并检索文献评估证据质量,发现关键风险人群的本地疾病负担数据存在显著缺口,且资金与人力不足。2016年KENITAG建议为6至23月龄儿童引入年度季节性流感疫苗,但以实施试点研究弥补本地数据缺口为前提,未推荐其他风险人群。

要点

  • 本地数据是NITAG决策的关键,缺乏时需采用科学可接受的方法利用他国证据。
  • KENITAG建议6至23月龄儿童接种季节性流感疫苗,但以试点研究为前提。
  • 因缺乏本地疾病负担数据,未推荐其他风险人群接种。

核心结论

  • 本地数据是NITAG决策的关键要素,但在缺乏本地数据尤其是疾病负担数据时,需采用科学可接受的方法利用他国研究结果来为本地决策提供信息。

研究设计与样本

  • 本研究为对KENITAG在2014年6月至2016年6月间生成的手册、报告和会议纪要的回顾性描述。

主要发现

  • KENITAG建立了推荐框架以识别关键、重要和非关键数据要素来指导讨论。
  • 文献检索在多个数据库进行,并使用关键评估技能计划(CASP)工具评估文献质量。
  • 孕妇、有合并症者、老年人和医务人员等关键风险人群的流感疾病负担存在显著知识缺口。
  • 资金不足和人力资源有限阻碍了KENITAG的活动。
  • 2016年KENITAG建议为6至23月龄儿童引入年度季节性流感疫苗,但以实施试点研究为前提;未推荐其他风险人群。

关键数值与推荐

  • 2016年KENITAG推荐为6至23月龄儿童接种年度季节性流感疫苗。
  • 该推荐以实施试点研究为前提,试点需解决流感疫苗接种规划的社会经济影响、疫苗递送策略以及对医护人员和现有免疫规划的影响等本地数据缺口。
  • 未推荐其他风险人群接种流感疫苗,原因是缺乏本地疾病负担数据。

局限性

  • 资金不足和人力资源有限阻碍了KENITAG的活动。
  • 关键风险人群的本地流感疾病负担数据存在显著缺口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2014 the Kenya National Immunization Technical Advisory Group (KENITAG) was asked by the Ministry of Health to provide an evidence-based recommendation on whether the seasonal influenza vaccine should be introduced into the national immunization program (NIP). METHODS: We reviewed KENITAG manuals, reports and meeting minutes generated between June 2014 and June 2016 in order to describe the process KENITAG used in arriving at that recommendation and the challenges encountered. RESULTS: KENITAG developed a recommendation framework to identify critical, important and non-critical data elements that would guide deliberations on the subject. Literature searches were conducted in several databases and the quality of scientific articles obtained was assessed using the Critical Appraisal Skills Programme tool. There were significant gaps in knowledge on the national burden of influenza disease among key risk groups, i.e., pregnant women, individuals with co-morbidities, the elderly and health care workers. Insufficient funding and limited work force hindered KENITAG activities. In 2016 KENITAG recommended introduction of the annual seasonal influenza vaccine among children 6 to 23 months of age. However, the recommendation was contingent on implementation of a pilot study to address gaps in local data on the socio-economic impact of influenza vaccination programs, strategies for vaccine delivery, and the impact of the vaccination program on the healthcare workforce and existing immunization program. KENITAG did not recommend the influenza vaccine for any other risk group due to lack of local burden of disease data. CONCLUSION: Local data are a critical element in NITAG deliberations, however, where local data and in particular burden of disease data are lacking, there is need to adopt scientifically acceptable methods of utilizing findings from other countries to inform local decisions in a manner that is valid and acceptable to decision makers.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Dawa J, Chaves SS, Ba Nguz A, et al. Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG). Vaccine. 2018. PMID: 30502070. doi:10.1016/j.vaccine.2018.11.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。